The Latest Breaking News from BWXT

The Trump administration's directive to accelerate plans for a nuclear reactor on the moon has sparked renewed speculation and market interest in companies such as OKLO Inc. (NYSE:OKLO) and BWX Technologies (NYSE:BWXT), highlighting the growing focus on a space-age energy race. Naturally, interest in nuclear-themed ETFs has taken the center…

On Friday, Cathie Wood-led Ark Invest made a series of significant trades, with Tesla Inc. (NASDAQ:TSLA), Roku Inc. (NASDAQ:ROKU), Archer Aviation Inc. (NASDAQ:ACHR), Aurora Innovation Inc. (NASDAQ:AUR), Kratos Defense Security Solutions Inc. (NASDAQ:KTOS), Coinbase Global Inc. (NASDAQ:COIN) and BWX Technologies Inc. (NYSE:BWXT)

With increasing geopolitical instability resulting in an uptick in defense spending and rapid digital transformation, the aerospace and defense industry’s outlook appears promising. Hence, quality defense stocks L3Harris (LHX), BWX Technologies (BWXT), and Kaman (KAMN) could be ideal buys for substantial gains this year. Read on….

Deployable microreactors could provide green power for operations that historically rely on generators and supply lines

BWX Technologies Inc (NYSE:BWXT) has secured a contract valued at ~C$130 million in support of Bruce Power’s Major Component Replacement (MCR) Project. The contract is for the fabrication and supply of replacement feeders for Bruce Power’s reactor units 3, 4, 5, 7 and 8 and represents an integral part of Bruce Power’s MCR…

BWX Technologies Inc (NYSE:BWXT) subsidiary BWXT Medical Ltd. has entered a commercial agreement with Bayer AG (OTC:BAYRY) to supply high-purity Actinium-225 (Ac-225). Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices. The parties expect supply to commence later this year. The above agreement follows the agreement reached by the parties in September 2021.…

BWX Technologies Inc (NYSE:BWXT) subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have established a licensing and services agreement. The agreement strengthens their existing partnership for the production of medical isotopes. It enables BWXT Medical to manufacture high purity Actinium-225 (Ac-225) based products for pharmaceutical companies as it continues to…

BWX Technologies, Inc. (NYSE:BWXT) has secured a contract from the U.S. Department of Defense (DoD) Strategic Capabilities Office (SCO) to build the first advanced nuclear microreactor in the U.S.  BWXT Advanced Technologies LLC will build the prototype in Lynchburg, Virginia, and Euclid, Ohio, under a cost-type contract valued at around $300 million, depending…

Pulled from Benzinga Pro data, BWX Technologies (NYSE:BWXT) posted Q1 earnings of $59.07 million, an increase from Q4 of 49.47%. Sales dropped to $531.00 million, a 10.3% decrease between quarters.